Discover

ORGO
Organogenesis Holdings Inc.
2.52
4 x 2.26
2 x 2.93
bid
ask
-
0.16
5.97%
08:43 AM
timesize
Ytd-51.35%
1y-47.72%
2.61
day range
2.68
2.04
52 week range
7.08
Open2.67Prev Close2.68Low2.61High2.68Mkt Cap344.85M
Vol1.33KAvg Vol1.07MEPS0.03P/E89.33Forward P/E-79.50
Beta1.33Short Ratio11.35Inst. Own48.25%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg2.47200-d Avg3.521yr Est5.00
Income Statement
Total Revenue37.23M
Revenues (USD)37.23M
Cost of Revenue25.77M
Gross Profit11.46M
Operating Expenses80.35M
Research and Development Expense15.16M
Selling, General and Administrative Expense65.19M
Operating Income-68.89M
Income Tax Expense-15.32M
Net Income-53.16M
Net Income Common Stock-56.16M
Net Income Common Stock (USD)-56.16M
Consolidated Income-53.16M
Earnings per Basic Share-0.44
Earnings per Basic Share (USD)-0.44
Earnings per Diluted Share-0.44
Earning Before Interest & Taxes (EBIT)-68.47M
Earning Before Interest & Taxes (USD)-68.47M
Preferred Dividends Income Statement Impact3.00M
Weighted Average Shares127.80M
Weighted Average Shares Diluted127.80M
Balance Sheet
Cash and Equivalents92.10M
Cash and Equivalents (USD)92.10M
Trade and Non-Trade Receivables116.91M
Current Assets268.50M
Property, Plant & Equipment Net157.82M
Total Assets519.99M
Debt Current9.72M
Total Debt70.86M
Current Liabilities76.02M
Debt Non-Current61.14M
Total Liabilities138.65M
Accumulated Retained Earnings (Deficit)-56.23M
Shareholders Equity244.56M
Shareholders Equity (USD)244.56M
Assets Non-Current251.49M
Total Debt (USD)70.86M
Goodwill and Intangible Assets32.21M
Inventory28.43M
Liabilities Non-Current62.62M
Trade and Non-Trade Payables28.62M
Tax Assets45.33M
Cash Flow
Depreciation, Amortization & Accretion12.37M
Net Cash Flow from Financing-20.21M
Net Cash Flow / Change in Cash & Cash Equivalents-2.23M
Capital Expenditure-3.15M
Issuance (Repayment) of Debt Securities -9.84M
Net Cash Flow from Investing-3.15M
Net Cash Flow from Operations21.13M
Share Based Compensation3.64M